{"id": "Mp7fQVMAAAAJ", "citedby": 8022, "citedby5y": 2691, "hindex": 43, "hindex5y": 23, "i10index": 72, "i10index5y": 42, "coauthors": [], "name": "Barbara J. Mason", "affiliation": "The Scripps Research Institute", "interests": ["Alcoholism", "Addiction"], "cites_per_year": {"1991": 20, "1992": 27, "1993": 32, "1994": 54, "1995": 58, "1996": 80, "1997": 88, "1998": 96, "1999": 100, "2000": 113, "2001": 163, "2002": 181, "2003": 209, "2004": 268, "2005": 240, "2006": 262, "2007": 296, "2008": 345, "2009": 302, "2010": 385, "2011": 343, "2012": 380, "2013": 454, "2014": 520, "2015": 530, "2016": 482, "2017": 451, "2018": 502, "2019": 542, "2020": 179}, "publications": [{"bib": {"title": "Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:u5HHmVD_uO8C", "citedby": "1723"}, {"bib": {"title": "An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions", "year": "2011"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:9yKSN-GCB0IC", "citedby": "560"}, {"bib": {"title": "A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:u-x6o8ySG0sC", "citedby": "339"}, {"bib": {"title": "A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence", "year": "1999"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:d1gkVwhDpl0C", "citedby": "332"}, {"bib": {"title": "A double\u2010blind, placebo\u2010controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCI for alcohol dependence", "year": "1994"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:2osOgNQ5qMEC", "citedby": "299"}, {"bib": {"title": "Gabapentin treatment for alcohol dependence: a randomized clinical trial", "year": "2014"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Tyk-4Ss8FVUC", "citedby": "247"}, {"bib": {"title": "Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:UeHWp8X0CEIC", "citedby": "222"}, {"bib": {"title": "Imipramine treatment for chronic depression", "year": "1988"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:qjMakFHDy7sC", "citedby": "217"}, {"bib": {"title": "Development of pharmacotherapies for drug addiction: a Rosetta stone approach", "year": "2009"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:zYLM7Y9cAGgC", "citedby": "177"}, {"bib": {"title": "Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study", "year": "2000"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:eJXPG6dFmWUC", "citedby": "170"}, {"bib": {"title": "Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:IjCSPb-OGe4C", "citedby": "167"}, {"bib": {"title": "A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:_FxGoFyzp5QC", "citedby": "158"}, {"bib": {"title": "Possible serotonin syndrome associated with tramadol and sertraline coadministration", "year": "1997"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:mvPsJ3kp5DgC", "citedby": "143"}, {"bib": {"title": "Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts", "year": "1993"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:D_sINldO8mEC", "citedby": "123"}, {"bib": {"title": "An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high\u2010risk veterans: the IMPROVE study", "year": "2000"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:VOx2b1Wkg3QC", "citedby": "117"}, {"bib": {"title": "Psychiatric comorbidity in methadone maintained patients", "year": "1998"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Y0pCki6q_DkC", "citedby": "116"}, {"bib": {"title": "A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone", "year": "2002"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:W7OEmFMy1HYC", "citedby": "115"}, {"bib": {"title": "Assessment of sulfonylurea adherence and metabolic control", "year": "1995"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:V3AGJWp-ZtQC", "citedby": "109"}, {"bib": {"title": "Sertraline treatment of co-occurring alcohol dependence and major depression", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:WF5omc3nYNoC", "citedby": "102"}, {"bib": {"title": "Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials", "year": "2000"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:eQOLeE2rZwMC", "citedby": "102"}, {"bib": {"title": "Ritanserin in the treatment of alcohol dependence\u2013a multi-center clinical trial", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:YsMSGLbcyi4C", "citedby": "100"}, {"bib": {"title": "Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals", "year": "2015"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:M3ejUd6NZC8C", "citedby": "98"}, {"bib": {"title": "Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals", "year": "2011"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:hqOjcs7Dif8C", "citedby": "98"}, {"bib": {"title": "Proof\u2010of\u2010concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin", "year": "2009"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:UebtZRa9Y70C", "citedby": "93"}, {"bib": {"title": "Desipramine treatment of alcoholism.", "year": "1991"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ufrVoPGSRksC", "citedby": "91"}, {"bib": {"title": "Imipramine and social-vocational adjustment in chronic depression.", "year": "1988"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:LkGwnXOMwfcC", "citedby": "91"}, {"bib": {"title": "Measurement of severity and treatment response in dysthymia", "year": "1993"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:roLk4NBRz8UC", "citedby": "90"}, {"bib": {"title": "Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment", "year": "2003"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Se3iqnhoufwC", "citedby": "89"}, {"bib": {"title": "Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems?", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:wbdj-CoPYUoC", "citedby": "83"}, {"bib": {"title": "Acamprosate for alcohol dependence: a sex\u2010specific meta\u2010analysis based on individual patient data", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:0EnyYjriUFMC", "citedby": "79"}, {"bib": {"title": "Medication and psychotherapy.", "year": "1994"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:5Ul4iDaHHb8C", "citedby": "75"}, {"bib": {"title": "Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:8k81kl-MbHgC", "citedby": "73"}, {"bib": {"title": "Acamprosate in the treatment of alcohol dependence", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:MXK_kJrjxJIC", "citedby": "73"}, {"bib": {"title": "Types of interventions made by clinical pharmacists in the IMPROVE study", "year": "2000"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:J-pR_7NvFogC", "citedby": "73"}, {"bib": {"title": "Existing and future drugs for the treatment of the dark side of addiction", "year": "2016"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:QIV2ME_5wuYC", "citedby": "70"}, {"bib": {"title": "Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics", "year": "2008"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:3fE2CSJIrl8C", "citedby": "68"}, {"bib": {"title": "Interpreting the findings of the IMPROVE study", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:q3oQSFYPqjQC", "citedby": "65"}, {"bib": {"title": "Plasma profile of pro\u2010inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co\u2010morbidity", "year": "2015"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Wp0gIr-vW9MC", "citedby": "61"}, {"bib": {"title": "COMBINE Study Research Group Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:_B80troHkn4C", "citedby": "60"}, {"bib": {"title": "Potential neuroprotective effects of acamprosate", "year": "2002"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:5nxA0vEk-isC", "citedby": "59"}, {"bib": {"title": "The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Zph67rFs4hoC", "citedby": "52"}, {"bib": {"title": "Effects of chronic, heavy cannabis use on executive functions", "year": "2011"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:4DMP91E08xMC", "citedby": "49"}, {"bib": {"title": "Adrenocortical function and suicidal behavior in depressive disorders", "year": "1986"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:KlAtU1dfN6UC", "citedby": "44"}, {"bib": {"title": "Prediction of response of chronic depression to imipramine", "year": "1989"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ULOm3_A8WrAC", "citedby": "43"}, {"bib": {"title": "Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:kNdYIx-mwKoC", "citedby": "42"}, {"bib": {"title": "Interpersonal psychotherapy for dysthymic disorders", "year": "1993"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:LPZeul_q3PIC", "citedby": "39"}, {"bib": {"title": "Dosing issues in the pharmacotherapy of alcoholism.", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:_kc_bZDykSQC", "citedby": "38"}, {"bib": {"title": "Schizophrenic, depressive, and nonpatient personality organizations described by Rorschach factor structures", "year": "1985"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:4TOpqqG69KYC", "citedby": "35"}, {"bib": {"title": "Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate \u2026", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:9ZlFYXVOiuMC", "citedby": "34"}, {"bib": {"title": "Rationale for combining acamprosate and naltrexone for treating alcohol dependence.", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:YOwf2qJgpHMC", "citedby": "33"}, {"bib": {"title": "Imipramine for treatment of chronic depression.", "year": "1985"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:qxL8FJ1GzNcC", "citedby": "32"}, {"bib": {"title": "Gabapentin for the treatment of alcohol use disorder", "year": "2018"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:AXPGKjj_ei8C", "citedby": "31"}, {"bib": {"title": "Prevalence, diagnosis, and treatment of comorbid mood disorders and alcoholism", "year": "1998"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:aqlVkmm33-oC", "citedby": "30"}, {"bib": {"title": "Emerging pharmacotherapies for alcohol use disorder", "year": "2017"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:NMxIlDl6LWMC", "citedby": "23"}, {"bib": {"title": "Acamprosate", "year": "2002"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:dhFuZR0502QC", "citedby": "20"}, {"bib": {"title": "Wound sepsis after colorectal surgery: the effect of cefotetan lavage.", "year": "1987"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:olpn-zPbct0C", "citedby": "16"}, {"bib": {"title": "Treatment of alcohol dependence with drug antagonists of the stress response", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:RHpTSmoSYBkC", "citedby": "15"}, {"bib": {"title": "Reduced Quality of Life in Veterans at Risk for Drug\u2010Related Problems", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:BrmTIyaxlBUC", "citedby": "15"}, {"bib": {"title": "Changes in Transaminases Over the Course of a 12\u2010Week, Double\u2010Blind Nalmefene Trial in a 38\u2010Year\u2010Old Female Subject", "year": "1994"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ZeXyd9-uunAC", "citedby": "15"}, {"bib": {"title": "The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:L8Ckcad2t8MC", "citedby": "14"}, {"bib": {"title": "Understanding and treating alcohol dependence", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:IWHjjKOFINEC", "citedby": "14"}, {"bib": {"title": "Cell patterning in pigment-chimeric eyes in Xenopus: germinal transplants and their contributions to growth of the pigmented retinal epithelium", "year": "1987"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:NJ774b8OgUMC", "citedby": "14"}, {"bib": {"title": "Gabapentin enacarbil extended\u2010release for alcohol use disorder: a randomized, double\u2010blind, placebo\u2010controlled, multisite trial assessing efficacy and safety", "year": "2019"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:N5tVd3kTz84C", "citedby": "13"}, {"bib": {"title": "Diagnostic criteria for dysthymic disorder.", "year": "1989"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:7PzlFSSx8tAC", "citedby": "13"}, {"bib": {"title": "Anemias", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ZfRJV9d4-WMC", "citedby": "12"}, {"bib": {"title": "Assessment of symptoms and change in dysthymic disorder", "year": "1995"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:eq2jaN3J8jMC", "citedby": "12"}, {"bib": {"title": "Suicide and adrenocortical function", "year": "1986"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:qUcmZB5y_30C", "citedby": "12"}, {"bib": {"title": "Stress, alcohol craving and relapse risk: mechanisms and viable treatment targets", "year": "2009"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:hC7cP41nSMkC", "citedby": "11"}, {"bib": {"title": "Measuring sleep disturbances in patients with alcohol use disorders: a short questionnaire suitable for routine practice", "year": "2015"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:JV2RwH3_ST0C", "citedby": "10"}, {"bib": {"title": "Acamprosate for alcohol dependence: An update for the clinician", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:-f6ydRqryjwC", "citedby": "10"}, {"bib": {"title": "Rapid and sensitive determination of nalmefene in human plasma by gas chromatography\u2013mass spectrometry", "year": "2002"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:hFOr9nPyWt4C", "citedby": "10"}, {"bib": {"title": "Women and minorities representation in alcoholism treatment research.", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:e5wmG9Sq2KIC", "citedby": "10"}, {"bib": {"title": "A translational approach to novel medication development for protracted abstinence", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:_Qo2XoVZTnwC", "citedby": "9"}, {"bib": {"title": "Method of treating nicotine dependence", "year": "1998"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:R3hNpaxXUhUC", "citedby": "9"}, {"bib": {"title": "Effects of nicotine and illicit substance use on alcoholism treatment outcomes and acamprosate efficacy", "year": "2009"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:4JMBOYKVnBMC", "citedby": "8"}, {"bib": {"title": "Results of the multicenter study of acamprosate in the treatment of alcoholism", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:HDshCWvjkbEC", "citedby": "8"}, {"bib": {"title": "Methodological issues in pharmacotherapy trials with alcoholics", "year": "1997"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:mB3voiENLucC", "citedby": "8"}, {"bib": {"title": "Cell patterning in pigment-chimeric eyes of Xenopus: local cues control the decision to become germinal cells", "year": "1987"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:uLbwQdceFCQC", "citedby": "8"}, {"bib": {"title": "How pilot studies improve large-scale clinical trials: lessons learned from the COMBINE Study.", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:bEWYMUwI8FkC", "citedby": "7"}, {"bib": {"title": "Desipramine in the treatment of depressed alcoholics.", "year": "1994"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:j3f4tGmQtD8C", "citedby": "7"}, {"bib": {"title": "Amoxapine versus amitriptyline for continuation therapy of depression.", "year": "1990"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:isC4tDSrTZIC", "citedby": "7"}, {"bib": {"title": "Acamprosate, alcoholism, and abstinence", "year": "2015"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:M3NEmzRMIkIC", "citedby": "6"}, {"bib": {"title": "CRF1 antagonists for anxiety", "year": "2003"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Fu2w8maKXqMC", "citedby": "6"}, {"bib": {"title": "Acamprosate treatment of alcohol dependence: results of the US multicenter study", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:iH-uZ7U-co4C", "citedby": "6"}, {"bib": {"title": "Preliminary dose finding for nalmefene treatment of alcoholism", "year": "1995"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:UHK10RUVsp4C", "citedby": "6"}, {"bib": {"title": "Neuroendocrine studies in depression: Relationship to suicidal behavior", "year": "1986"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:TFP_iSt0sucC", "citedby": "6"}, {"bib": {"title": "A review of the suicide constellation", "year": "1984"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:JoZmwDi-zQgC", "citedby": "6"}, {"bib": {"title": "Methodology of the US multicenter study of acamprosate in alcohol dependence", "year": "1998"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:k_IJM867U9cC", "citedby": "3"}, {"bib": {"title": "Human laboratory models of addiction", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:hMod-77fHWUC", "citedby": "2"}, {"bib": {"title": "Alcohol abuse among older adults and the elderly", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:blknAaTinKkC", "citedby": "2"}, {"bib": {"title": "P-10-17 Preliminary dose finding for nalmefene treatment of alcoholism", "year": "1995"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:TQgYirikUcIC", "citedby": "2"}, {"bib": {"title": "Subtherapeutic serum drug concentrations and compliance", "year": "1991"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:HE397vMXCloC", "citedby": "2"}, {"bib": {"title": "Psychiatry Comorbidity in Methadome Maintained Patients", "year": "1991"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:maZDTaKrznsC", "citedby": "2"}, {"bib": {"title": "ALTERATION OF ADRENERGIC-RECEPTOR RESPONSIVITY BY ELECTROCONVULSIVE-THERAPY AND RELATIONSHIP TO ANTIDEPRESSANT OUTCOME", "year": "1987"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:RGFaLdJalmkC", "citedby": "2"}, {"bib": {"title": "A human laboratory study of mifepristone as a novel treatment for alcohol use disorder", "year": "2017"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:vRqMK49ujn8C", "citedby": "1"}, {"bib": {"title": "IDENTIFYING POTENTIAL CLINICAL PREDICTORS OF ACAMPROSATE RESPONSE WITH A HUMAN LABORATORY MODEL OF PROTRACTED WITHDRAWAL: 181", "year": "2015"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:GnPB-g6toBAC", "citedby": "1"}, {"bib": {"title": "Gabapentin Treatment for Alcohol Dependence\u2014Reply", "year": "2014"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:NaGl4SEjCO4C", "citedby": "1"}, {"bib": {"title": "O4. 5ACAMPROSATE FOR IMPROVING CONTROLLED DRINKING: IMPACT OF TREATMENT DURATION ON THERAPY SUCCESS", "year": "2011"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:zA6iFVUQeVQC", "citedby": "1"}, {"bib": {"title": "Methods for treating substance dependence", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:BqipwSGYUEgC", "citedby": "1"}, {"bib": {"title": "PREDICTION OF DRINKING AND CLINICAL OUTCOME STATUS FOLLOWING TREATMENT WITH NALTREXONE AND ACAMPROSATE: RESULTS FROM THE COMBINE STUDY 033", "year": "2008"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:RYcK_YlVTxYC", "citedby": "1"}, {"bib": {"title": "WOMEN AND ALCOHOLISM: A META-ANALYSIS OF OUTCOME PREDICTORS BASED ON 935 FEMALE PATIENTS IN 16 ACAMPROSATE CLINICAL TRIALS 198", "year": "2007"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:O3NaXMp0MMsC", "citedby": "1"}, {"bib": {"title": "Individual patient data meta-analysis of predictors of outcome including USA and European studies", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:YFjsv_pBGBYC", "citedby": "1"}, {"bib": {"title": "Naltrexone treatment for concurrent tobacco and alcohol dependence.", "year": "2004"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:J_g5lzvAfSwC", "citedby": "1"}, {"bib": {"title": "Treatment of dysthymia", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ns9cj8rnVeAC", "citedby": "1"}, {"bib": {"title": "Encainide-induced hyperglycemia", "year": "1989"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:XiVPGOgt02cC", "citedby": "1"}, {"bib": {"title": "Comparison of cefotetan and gentamicin/ampicillin in high-risk biliary tract surgery.", "year": "1987"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Mojj43d5GZwC", "citedby": "1"}, {"bib": {"title": "The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda", "year": "2020"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:vDijr-p_gm4C", "citedby": "0"}, {"bib": {"title": "The future of translational research on alcohol use disorder", "year": "2020"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:epqYDVWIO7EC", "citedby": "0"}, {"bib": {"title": "PRECLINICAL AND CLINICAL EVIDENCE FOR TARGETED PHARMACOTHERAPY FOR ALCOHOL USE DISORDER", "year": "2019"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:2KloaMYe4IUC", "citedby": "0"}, {"bib": {"title": "Pharmacological treatment of alcohol use disorder.", "year": "2019"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:j8SEvjWlNXcC", "citedby": "0"}, {"bib": {"title": "Anticonvulsants to Treat Cannabis Use Disorder", "year": "2019"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ZuybSZzF8UAC", "citedby": "0"}, {"bib": {"title": "Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of substance use disorders", "year": "2018"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:1yQoGdGgb4wC", "citedby": "0"}, {"bib": {"title": "Larry Parsons: Researcher, mentor, and friend", "year": "2018"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:PR6Y55bgFSsC", "citedby": "0"}, {"bib": {"title": "PRECLINICAL AND CLINICAL EVIDENCE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS AS POTENTIAL NEW MEDICATIONS FOR ALCOHOL USE DISORDERS", "year": "2018"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:hkOj_22Ku90C", "citedby": "0"}, {"bib": {"title": "Measuring Sleep Disturbances in Patients With Alcohol Use Disorders", "year": "2015"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ipzZ9siozwsC", "citedby": "0"}, {"bib": {"title": "CLINICAL VALIDATION OF CENTRAL STRESS SYSTEMS AS A PHARMACOLOGICAL TARGET IN TREATING ALCOHOLISM: A RANDOMIZED CONTROLLED TRIAL OF GABAPENTIN: 184", "year": "2014"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:nb7KW1ujOQ8C", "citedby": "0"}, {"bib": {"title": "Referat\u2013Behandlung mit Gabapentin bei Alkoholabh\u00e4ngigkeit", "year": "2014"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:cFHS6HbyZ2cC", "citedby": "0"}, {"bib": {"title": "A Glucocorticoid Antagonist Shows Therapeutic Potential for Alcohol Dependence in a POC Human Laboratory Study", "year": "2014"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:xtRiw3GOFMkC", "citedby": "0"}, {"bib": {"title": "Gabapentine pour le traitement de la d\u00e9pendance \u00e0 l\u2019alcool: des r\u00e9sultats \u00e0 confirmer", "year": "2014"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "Interventions For Addiction: Chapter 40. Acamprosate for Alcohol Dependence", "year": "2013"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:8AbLer7MMksC", "citedby": "0"}, {"bib": {"title": "PREDICTIVE VALIDITY OF A HUMAN LABORATORY MODEL FOR MEDICATION DEVELOPMENT IN ALCOHOL DEPENDENCE: S268", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:35N4QoGY0k4C", "citedby": "0"}, {"bib": {"title": "STRESS AND CRAVING: PREDICTING ALCOHOL TREATMENT OUTCOMES USING A HUMAN LABORATORY PARADIGM OF INTERPERSONAL STRESS INDUCTION: 0363", "year": "2012"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:1sJd4Hv_s6UC", "citedby": "0"}, {"bib": {"title": "FREE ORAL COMMUNICATIONS 4: ALCOHOL DEPENDENCE: TREATMENT APPROACHES O4. 1 EFFECTIVENESS OF STIMULANT MEDICATION IN FETAL ALCOHOL SPECTRUM DISORDERS", "year": "2011"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:rO6llkc54NcC", "citedby": "0"}, {"bib": {"title": "Clinical Treatments Roundtable", "year": "2011"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:b0M2c_1WBrUC", "citedby": "0"}, {"bib": {"title": "Mpzp: a small molecule corticotropin-releasing factor type 1 receptor (crf1) antogonist", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:OU6Ihb5iCvQC", "citedby": "0"}, {"bib": {"title": "The new pharmacotherapies for alcohol dependence", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:uWQEDVKXjbEC", "citedby": "0"}, {"bib": {"title": "HUMAN LABORATORY AND CLINICAL TRIAL EVIDENCE FOR GABAPENTIN TREATMENT OF ALCOHOL DEPENDENCE: S195", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:CHSYGLWDkRkC", "citedby": "0"}, {"bib": {"title": "EFFECT OF ACAMPROSATE ON SLEEPING DISORDERS DURING A 24-WEEK FOLLOW-UP AFTER ALCOHOL WITHDRAWAL IN A COHORT OF 592 ALCOHOL-DEPENDENT PATIENTS: P319", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:lSLTfruPkqcC", "citedby": "0"}, {"bib": {"title": "GABAPENTIN IN ALCOHOLISM: FROM LABORATORY STUDY TO CLINICAL TRIAL: FC14. 2.4", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:p2g8aNsByqUC", "citedby": "0"}, {"bib": {"title": "SUBSYNDROMAL DISTURBANCES IN MOOD AND SLEEP AND RELAPSE PREVENTION IN ALCOHOL DEPENDENCE: RESULTS OF A RANDOMIZED CONTROLLED TRIAL: 181", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:K3LRdlH-MEoC", "citedby": "0"}, {"bib": {"title": "CUE-REACTIVITY IN ALCOHOL DEPENDENT VOLUNTEERS TREATED WITH ACAMPROSATE, NALREXONE, OR PLACEBO: FMRI FINDINGS IN RELATION TO HUMAN LABORATORY RESULTS: 665", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:u_35RYKgDlwC", "citedby": "0"}, {"bib": {"title": "A Neuromodulatory approach to subsyndromal disturbances in mood and sleep and relapse prevention in alcohol dependence: Results of a randomized controlled trial", "year": "2010"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:WbkHhVStYXYC", "citedby": "0"}, {"bib": {"title": "EFFECTS OF ACAMPROSATE IN THE COMBINE STUDY: A CELL X CELL COMPARISON: 122", "year": "2009"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:a0OBvERweLwC", "citedby": "0"}, {"bib": {"title": "guest editorial\u2022 guest editorial", "year": "2008"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:LjlpjdlvIbIC", "citedby": "0"}, {"bib": {"title": "Challenges in Comorbidity", "year": "2008"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:NhqRSupF_l8C", "citedby": "0"}, {"bib": {"title": "A human laboratory model of risk factors for relapse in alcohol dependence and for predicting medication efficacy", "year": "2008"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:EUQCXRtRnyEC", "citedby": "0"}, {"bib": {"title": "ACAMPROSATE EFFICACY IN ALCOHOL-DEPENDENT PATIENTS: EFFECT OF NICOTINE AND ILLICIT SUBSTANCE USE ON TREATMENT OUTCOMES 985", "year": "2008"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:dfsIfKJdRG4C", "citedby": "0"}, {"bib": {"title": "Challenges in Comorbidity-The aim of this issue of Psychiatric Annals is to convey state-of-the-art information about diagnosing and treating anxiety, bipolar, and depressive \u2026", "year": "2008"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:tS2w5q8j5-wC", "citedby": "0"}, {"bib": {"title": "MULTIPLE TIME TO EVENT ANALYSES OF DRINKING IN THE COMBINE STUDY: 195", "year": "2007"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:pyW8ca7W8N0C", "citedby": "0"}, {"bib": {"title": "Can goal oriented therapy for rheumatoid arthritis improve functional outcome?", "year": "2007"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ye4kPcJQO24C", "citedby": "0"}, {"bib": {"title": "Secondary failure of adalimumab (Humira) in rheumatoid arthritis patients", "year": "2007"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:5awf1xo2G04C", "citedby": "0"}, {"bib": {"title": "An individual Patient Data Meta Analysis on alcoholic women patients treated with acamprosate", "year": "2007"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:PELIpwtuRlgC", "citedby": "0"}, {"bib": {"title": "The effect of gabapentin on subjective sleep quality and daytime function in an alcoholdependent sample attempting abstinence: A double-blind placebo-controlled trial", "year": "2007"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:tOudhMTPpwUC", "citedby": "0"}, {"bib": {"title": "USING ACAMPROSATE IN THE USA: 111", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:EkHepimYqZsC", "citedby": "0"}, {"bib": {"title": "BACKGROUND AND RATIONALE FOR THE COMBINE STUDY: 328", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:3s1wT3WcHBgC", "citedby": "0"}, {"bib": {"title": "Using acamprosate in the USA", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:vV6vV6tmYwMC", "citedby": "0"}, {"bib": {"title": "Acamprosate and other treatments for alcoholism", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:2P1L_qKh6hAC", "citedby": "0"}, {"bib": {"title": "PHARMACOTHERAPIES COMBINEES ET INTERVENTIONS COMPORTEMENTALES DANS LA DEPENDANCE ALCOOLIQUE: L'ETUDE COMBINE: ESSAI RANDOMISE ET COMPARATIF", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:l7t_Zn2s7bgC", "citedby": "0"}, {"bib": {"title": "Women and Alcoholism: An Individual Patient Data (IPD) Meta-Analysis of Outcome Predictors Based on 935 Female Patients in 16 Acamprosate Clinical Trials", "year": "2006"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Y5dfb0dijaUC", "citedby": "0"}, {"bib": {"title": "Development and validation of human laboratory models for the prediction of medication efficacy in clinical trials", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:pqnbT2bcN3wC", "citedby": "0"}, {"bib": {"title": "Acamprosate response in clinical sub-types of alcohol dependence: A review of the integrated summary of efficacy", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:P5F9QuxV20EC", "citedby": "0"}, {"bib": {"title": "Individual Patient Data Meta-Analysis of Predictors of Outcome Across US", "year": "2005"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:SdhP9T11ey4C", "citedby": "0"}, {"bib": {"title": "Naltrexone maintenance treatment of alcohol dependence", "year": "2004"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:yD5IFk8b50cC", "citedby": "0"}, {"bib": {"title": "Individual Patient Data Meta-Analysis of Predictors of Outcome Across US and European Acamprosate Studies", "year": "2003"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:9vf0nzSNQJEC", "citedby": "0"}, {"bib": {"title": "S. 13.01 CRF 1 antagonists for anxiety", "year": "2003"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:r0BpntZqJG4C", "citedby": "0"}, {"bib": {"title": "Book Review: Communicating with Today's Patient: Essentials to Save Time, Decrease Risk, and Increase Patient Compliance", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:bnK-pcrLprsC", "citedby": "0"}, {"bib": {"title": "A Double-Blind, Placebo-controlled Study of Oral Nalmefene for Alcohol Dependence", "year": "2001"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:zLWjf1WUPmwC", "citedby": "0"}, {"bib": {"title": "PHARMACY PRACTICE INSIGHTS-Types of Interventions Made by Clinical Pharmacists in the IMPROVE Study", "year": "2000"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:W5xh706n7nkC", "citedby": "0"}, {"bib": {"title": "GENERAL PSYCHIATRY", "year": "1999"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:Tiz5es2fbqcC", "citedby": "0"}, {"bib": {"title": "Naltrexone and/or sertraline in outpatients with alcoholism and depression", "year": "1998"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:dshw04ExmUIC", "citedby": "0"}, {"bib": {"title": "Sertraline interaction", "year": "1997"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:fQNAKQ3IYiAC", "citedby": "0"}, {"bib": {"title": "The in vitro metabolism, macromolecular binding and bacterial mutagenicity of 4-chlorobiphenyl, a model PCB substrate", "year": "1997"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:VL0QpB8kHFEC", "citedby": "0"}, {"bib": {"title": "Nalmefene modification of alcoholism", "year": "1997"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:738O_yMBCRsC", "citedby": "0"}, {"bib": {"title": "Introduction to the Supplement", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:7T2F9Uy0os0C", "citedby": "0"}, {"bib": {"title": "Use of Desipramine in Recovering Alcoholics", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:UxriW0iASnsC", "citedby": "0"}, {"bib": {"title": "Effect of chronic ethanol treatment on hippocampal CA3 neurons", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:u9iWguZQMMsC", "citedby": "0"}, {"bib": {"title": "Neural mechanisms underlying alcohol's reinforcing properties", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:SP6oXDckpogC", "citedby": "0"}, {"bib": {"title": "Use of a Medication Event Monitoring System to Assess Sulfonylurea Timing and Dosing Intervals", "year": "1996"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:1qzjygNMrQYC", "citedby": "0"}, {"bib": {"title": "Pharmacotherapy for alcoholism treatment with psychiatric comorbidity", "year": "1994"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:KxtntwgDAa4C", "citedby": "0"}, {"bib": {"title": "Medication Noncompliance", "year": "1989"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:kRWSkSYxWN8C", "citedby": "0"}, {"bib": {"title": "Methods and Issues in Psychopharmacologicals Studies", "year": "1988"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ZHo1McVdvXMC", "citedby": "0"}, {"bib": {"title": "CONCOMITANT PSYCHIATRIC AND MEDICAL DISORDERS IN ALCOHOLIC INPATIENTS-RESEARCH AND TREATMENT ISSUES", "year": "1988"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:bFI3QPDXJZMC", "citedby": "0"}, {"bib": {"title": "in Psychopharmacological Studies", "year": "1988"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:uc_IGeMz5qoC", "citedby": "0"}, {"bib": {"title": "A comparison of cefuroxime and cefotetan in the prevention of wound sepsis after gastrointestinal surgery.", "year": "1987"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:WA5NYHcadZ8C", "citedby": "0"}, {"bib": {"title": "A multicenter open clinical trial of cefotetan in the treatment of peritonitis.", "year": "1987"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:t6usbXjVLHcC", "citedby": "0"}, {"bib": {"title": "The Use of Cefotetan in Surgical Prophylaxis", "year": "1985"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:5ugPr518TE4C", "citedby": "0"}, {"bib": {"title": "SEIZURE LENGTH AS A PREDICTOR OF REMISSION OF DEPRESSION.", "year": "1984"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:ldfaerwXgEUC", "citedby": "0"}, {"bib": {"title": "Neuroendocrine Studies in Depression", "year": "1877"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:08ZZubdj9fEC", "citedby": "0"}, {"bib": {"title": "Over Half of Veterans Given Opioids Become Chronic Users"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:uJ-U7cs_P_0C", "citedby": "0"}, {"bib": {"title": "To~ o, 1977, V3,~ 63-h68. Publ Tokyo: Japan SOC S~, 1978"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:35r97b3x0nAC", "citedby": "0"}, {"bib": {"title": "Glucocorticoid Receptor Antagonism Decreases Alcohol Seeking in Alcohol Dependence"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:JQOojiI6XY0C", "citedby": "0"}, {"bib": {"title": "Jack G. Wiggins, Jr."}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:tkaPQYYpVKoC", "citedby": "0"}, {"bib": {"title": "Research Review for March 2014"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:HoB7MX3m0LUC", "citedby": "0"}, {"bib": {"title": "Gender differences related to age and ethnicity in a multi-site alcohol clinical trial"}, "source": "citations", "id_citations": "Mp7fQVMAAAAJ:70eg2SAEIzsC", "citedby": "0"}]}